Visiogen, Inc. Launches New Website.

New Interactive Educational Website is the Online Home of the Synchrony[R] 3-Dimensional Dual Optic Accommodating Intraocular Lens

IRVINE, Calif. -- Visiogen, Inc. of Irvine, California, today announced the launch of its new website, found at www.visiogen.com. This interactive educational website is aimed at introducing both ophthalmologists and patients to the Synchrony[R] 3-dimensional dual optic accommodating intraocular lens (AIOL) and preloaded injector.

Features of the website include a library of publications defining the Synchrony technology, surgical footage showing implantation of the lens, and illustrations of the improved visual acuity the Synchrony system is designed to provide. The site includes an interactive 3-D lens model that lets visitors fully rotate and zoom in on the lens image, allowing them to get acquainted with the dynamic lens structure. Animation, photos and presentation materials demonstrating the attributes of Synchrony and supporting its potential validity are also included on the site.

The entire Synchrony system is self-contained and ready for use without the need for lens handling by means of a preloaded injector system. The dual optic lens is designed to be inserted through a 3.6 - 3.8 mm clear-corneal incision. The single-piece 3-dimensional lens unfolds in the eye upon insertion and features two optics connected by a spring system. The springs connect a 5.5-mm high power anterior optic and a 6-mm minus power posterior optic; the spring action moves the front optic and changes the eye's focus from near to far.

To date, the Synchrony lens has been implanted in over 800 eyes worldwide. The European CE Mark for the Synchrony[R] Dual Optic Accommodating IOL was received in June of 2006 and post-marketing research studies are currently underway within Europe to further build the scientific foundation for Synchrony.

The Synchrony lens is currently an investigational device in the United States and is being studied in a pivotal clinical trial at 20 sites within the U.S. This study is evaluating the safety and effectiveness of the device and the potential for near, intermediate and distance vision without the use of spectacles in patients post cataract surgery.

About Visiogen

Visiogen, Inc. is focused on developing innovative products for cataract and refractive patients. Founded in Irvine, California, in 2001, Visiogen's first commercial application, Synchrony[R], a 3-dimensional dual optic accommodating intraocular lens and pre-loaded injector, is currently in clinical studies in the U.S. and has received the CE Mark in Europe.

More information on the company and its offerings can be obtained by contacting:

Chuck Brauer or Kate Jennings
Maricich Communications for Visiogen, Inc.
Tel. [phone]
Fax [phone]
[e-mail]